Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unacylated Ghrelin to Improve Functioning in PAD: The GIFT Trial Phase II
NCT04377126Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jul 2020
- Primary completion
- Jan 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of unacylated ghrelin in peripheral artery disease (PAD), sponsored by Northwestern University. Started Jul 2020; status: completed.
02
Drugs
unacylated ghrelin
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT04377126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377126.